Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Medtronic plcNYSE: MDT

Accounts Payables · Q1 FY2027 · quarter ended Jul 2026

Accounts payables declines year over year

Q1 FY2027 accounts payables of $531M (cash outflow) fell 11.2% year over year, ahead of the -47.4% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -59.6% a year.

Context

  • Accounts payables amounted to 0.1% of revenue in FY2026, down 0.5 pp from a year earlier.
  • Accounts payables increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -11.2% holds above the trailing-twelve-month pace of -47.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
-$531M-531.7% QoQ
Last fiscal yearApr 2026
$46M-78.0% YoY
LTMJul 2026
$113M-47.4% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.2%——
1 year-78.0%——
3-year CAGR-59.6%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2026
46M USD
Year-over-year change
-78.0%
4-year CAGR
-31.8%

Accounts Payables vs competitors

How MDT compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -47.4% is the 8th highest of 9, against a peer median of +145.2%.
  • Accounts payables amounts to 0.3% of revenue for MDT, versus a peer median of 0.9%.
MDT Competitors
Accounts Payables for MDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$236M USD+84.4%-31.3%0.9%
BSXBoston Scientific CorporationLTM Jun 2026$172M USD-63.2%—0.8%
EWEdwards Lifesciences CorporationLTM Jun 2026$171.4M USD+532.5%—2.6%
MDTMedtronic plcLTM Jul 2026$113M USD-47.4%-59.6%0.3%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$61.4M USD+161.3%-0.4%0.7%
PHGKoninklijke Philips N.V.LTM Jun 2026€19.11M EUR+110.0%—0.1%
PENPenumbra, Inc.LTM Jun 2026$16.92M USD+451.0%-38.8%1.1%
LIVNLivaNova PLCLTM Sep 2026$7.89M USD+129.1%+56.4%0.5%
AVRAnteris Technologies Global Corp.LTM Mar 2026$887K USD+2749.0%—47.9%
Peer median (excluding MDT) —+145.2%-15.8%0.9%

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Net Income5.06B3.78B3.68B4.69B4.84B
Depreciation & Amortization2.71B2.7B2.65B2.86B2.96B
Deferred Income Tax(604M)(226M)(508M)(316M)51M
Stock-Based Compensation359M355M393M429M457M
Change in Working Capital(889M)(967M)(484M)(1.05B)(1.42B)
Accounts Receivables(477M)(576M)(391M)(433M)(200M)
Inventory(560M)(939M)(139M)(292M)(404M)
Accounts Payables213M696M391M209M46M
Other Working Capital(65M)(148M)(345M)(538M)(865M)
Other Non-Cash Items711M396M1.06B433M450M
Operating Cash Flow7.35B6.04B6.79B7.04B7.33B
Capital Expenditures(1.37B)(1.46B)(1.59B)(1.86B)(1.9B)
Acquisitions (Net)(91M)(1.87B)(211M)(98M)(406M)
Purchases of Investments(9.88B)(7.51B)(7.75B)(8.23B)(8.73B)
Sales of Investments9.69B7.34B7.44B8.5B8.11B
Other Investing Activities(10M)4M(261M)(249M)(4M)
Investing Cash Flow(1.66B)(3.49B)(2.37B)(1.94B)(2.93B)
Debt Repayment(1M)(598M)1.07B2.14B(1.17B)
Common Stock Issued429M308M284M508M516M
Common Stock Repurchased(2.54B)(645M)(2.14B)(3.24B)(1.04B)
Dividends Paid(3.38B)(3.62B)(3.67B)(3.59B)(3.64B)
Other Financing Activities163M(101M)(3M)(184M)582M
Financing Cash Flow(5.34B)(4.96B)(4.45B)(4.36B)(4.75B)
Effect of Forex Changes(230M)243M(230M)188M85M
Net Change in Cash121M(2.17B)(259M)934M(269M)
Free Cash Flow5.98B4.58B5.2B5.19B5.43B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.